Cargando…
Hemostatic challenges in patients with chronic immune thrombocytopenia treated with eltrombopag
Chronic immune thrombocytopenia (ITP) is an autoimmune disease that results in chronically low platelet counts. Treatment guidelines recommend a platelet count of at least 50 000/µl before minor surgery and at least 80 000/µl before major surgery. This retrospective analysis explored invasive non-de...
Autores principales: | Tarantino, Michael D., Bakshi, Kalpana K., Brainsky, Andrés |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Informa UK Ltd.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913069/ https://www.ncbi.nlm.nih.gov/pubmed/23402314 http://dx.doi.org/10.3109/09537104.2013.764980 |
Ejemplares similares
-
Spotlight on eltrombopag in the treatment of children with chronic immune thrombocytopenia
por: Lambert, Michele P
Publicado: (2016) -
A Comment on Boyers et al.: “Eltrombopag for the Treatment of Chronic Immune or Idiopathic Thrombocytopenic Purpura: A NICE Single Technology Appraisal”
por: Allen, Rachel, et al.
Publicado: (2012) -
Successful Use of Eltrombopag in a Young Child With Chronic Immune Thrombocytopenia
por: Gruhn, Bernd, et al.
Publicado: (2021) -
Eltrombopag Effectiveness and Tolerability in Chronic Immune
Thrombocytopenia: A Meta-Analysis
por: Ahmed, Hafiz Abdul Waqas, et al.
Publicado: (2021) -
A case of immune thrombocytopenia associated with invasive thymoma successfully treated with eltrombopag
por: Yoon, Jung-Ki, et al.
Publicado: (2019)